Carlsmed, Inc., announced today the U.S. launch of the aprevo® patient-specific spine technology and the New Technology Add-On Payment (NTAP) reimbursement.
"We are grateful for our surgeon partners that worked with the company early on to develop a truly personalized solution for patients and to collect the clinical data for improved outcomes," said Mike Cordonnier, CEO of Carlsmed. "We would like to recognize Dr. Christopher Ames at University of California San Francisco, Dr. Vijay Yanamadala at Hartford Healthcare, and Dr. Justin Smith at the University of Virginia Medical Center. These talented surgeons and their dedicated staff collaborated with Carlsmed and patients to complete the first in world aprevo® anterior, lateral, and transforaminal procedures respectively earlier this year as part of a Limited Clinical Release."
Comments